What is Primary Pulmonary Hypertension (PPH)?
Primary Pulmonary Hypertension (PPH) is a rare disorder that leads to high blood pressure in the lungs. Persons with PPH usually have the condition for years without knowing it because the symptoms develop slowly over time.
What are the Symptoms of Symptoms of PPH?
Symptoms often include:
- Rapid heartbeat
- Chest pain
As the condition worsens, symptoms can expand to include
- Shortness of breath
- Swelling of the ankles and legs
- Bluish tinge to the lips and skin
How is PPH Treated?
Currently there is no cure for Primary Pulmonary Hypertension. Treatments are designed to help alleviate symptoms and slow the progression of the disease. The type of treatment administered will depend upon several factors.
Methods include various medications, including diuretics to reduce water buildup in the body, blood thinners and Digoxin, a medication designed to strengthen the heartbeat and help the body pump more blood. Oxygen therapy, surgery and various lifestyle changes may also be recommended.
Fen-Phen and Other Diet Drugs Linked to PPH
The once popular diet drug Fen-Phen has been linked to an increase in the risk for heart damage, including the development of primary pulmonary hypertension. Since 1994, the FDA has received and reported hundreds of reports of adverse events linked to diet pills containing ephedra, including Fen-Phen. Despite the known risks, Fen-Phen diet pills are still available for purchase over-the-counter.
If your or someone you love developed PPH and you have a history of using diet pills Fen-Phen, Adipex, Redux or Pondimin, you may be eligible for financial compensation. To learn more about your legal options, please call (800) 391-6415.
May 12th, 2015
In societies where thinness is valued, it follows that there will be a constant struggle for people to lose weight. Since the dawn of modern medicine, that struggle has been met with countless drugs designed to make losing weight easy... read more
May 6th, 2014
Canadians with pulmonary hypertension are struggling with the complications of the disease, according to results from a Canadian study, released yesterday from the Pulmonary Hypertension Association (PHA) of Canada's Patient and Caregiver Survey.
Study authors based their findings on a... read more
May 26th, 2005
According to a new study from the University of Pennsylvania, women who undergo lung transplants are more likely than men to experience a certain type of injury afterwards.
The senior researcher of the study,... read more